Medication leaflets

Active substance

Results for the substance pasireotide

8 results

About this active substance

Pasireotide is a somatostatin analog used in the treatment of Cushing's disease and acromegaly in patients who cannot undergo surgery. It works by inhibiting the secretion of adrenocorticotropic hormone (ACTH) or growth hormone.

The medication is administered subcutaneously or intramuscularly, as directed by a doctor, usually once a month for long-acting formulations. It is important for patients to follow the treatment regimen and undergo regular tests to monitor hormone levels.

Patients should be aware of potential side effects, such as hyperglycemia, diarrhea, or pain at the injection site. It is important to inform the doctor of any unusual symptoms.

Common side effects include hyperglycemia, diarrhea, and pain at the injection site. In rare cases, severe reactions such as liver failure or pancreatitis may occur. Patients should be informed of these risks before use.